Literature DB >> 22358461

Left heart bypass support with the Rotaflow Centrifugal Pump® as a bridge to decision and recovery in an adult.

Koichi Kashiwa1, Takashi Nishimura, Aya Saito, Hitoshi Kubo, Aoi Fukaya, Hisayoshi Tamai, Tomoyuki Yambe, Shunei Kyo, Minoru Ono.   

Abstract

Since left heart bypass or biventricular circulatory assist with an extracorporeal centrifugal pump as a bridge to decision or recovery sometimes requires long-time support, the long-term durability of extracorporeal centrifugal pumps is crucial. The Rotaflow Centrifugal Pump(®) (MAQUET Cardiopulmonary AG, Hirrlingen, Germany) is one of the centrifugal pumps available for long-term use in Japan. However, there have been few reports of left heart bypass or biventricular circulatory support over the mid-term. This is a case report of left heart bypass support with the Rotaflow Centrifugal Pump(®) as a bridge to decision and recovery for an adult patient who could not be weaned from cardiopulmonary bypass and percutaneous cardiopulmonary support after cardiac surgery. We could confirm that the patient's consciousness level was normal; however, the patient could not be weaned from the left heart bypass support lasting 1 month. Therefore, the circulatory assist device was switched to the extracorporeal Nipro ventricular assist device (VAD). This time, left heart bypass support could be maintained for 30 days using a single Rotaflow Centrifugal Pump(®). There were no signs of hemolysis during left heart bypass support. The Rotaflow Centrifugal Pump(®) itself may be used as a device for a bridge to decision or recovery before using a VAD in cardiogenic shock patients.

Entities:  

Mesh:

Year:  2012        PMID: 22358461     DOI: 10.1007/s10047-012-0632-x

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  6 in total

1.  Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator.

Authors:  Tomohiro Nishinaka; Eisuke Tatsumi; Nobumasa Katagiri; Hiroyuki Ohnishi; Toshihide Mizuno; Kyoko Shioya; Tomonori Tsukiya; Akihiko Homma; Susumu Kashiwabara; Hidenori Tanaka; Masaki Sato; Yoshiyuki Taenaka
Journal:  J Artif Organs       Date:  2007-12-20       Impact factor: 1.731

2.  Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation.

Authors:  Hiroo Takayama; Jonathan M Chen; Ulrich P Jorde; Yoshifumi Naka
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-11-02

3.  The first successful use of the Levitronix PediMag ventricular support device as a biventricular bridge to transplant in an infant.

Authors:  Rabin Gerrah; Kevin Charette; Jonathan M Chen
Journal:  J Thorac Cardiovasc Surg       Date:  2011-05-06       Impact factor: 5.209

4.  Seal-less centrifugal blood pump with magnetically suspended rotor: rot-a-flot.

Authors:  N Mendler; F Podechtl; G Feil; P Hiltmann; F Sebening
Journal:  Artif Organs       Date:  1995-07       Impact factor: 3.094

5.  Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support.

Authors:  Ranjit John; James W Long; H Todd Massey; Bartley P Griffith; Benjamin C Sun; Alfred J Tector; O Howard Frazier; Lyle D Joyce
Journal:  J Thorac Cardiovasc Surg       Date:  2010-07-06       Impact factor: 5.209

6.  Left ventricular assist device support with a centrifugal pump for 2 months in a 5-kg child.

Authors:  Takafumi Inoue; Takashi Nishimura; Arata Murakami; Keiichi Itatani; Tetsuhiro Takaoka; Kazuo Kitahori; Akihide Umeki; Toshiko Takezoe; Koichi Kashiwa; Shunei Kyo; Minoru Ono
Journal:  J Artif Organs       Date:  2011-05-20       Impact factor: 1.731

  6 in total
  9 in total

Review 1.  Current status of extracorporeal ventricular assist devices in Japan.

Authors:  Takashi Nishimura
Journal:  J Artif Organs       Date:  2014-06-22       Impact factor: 1.731

2.  Preclinical study of a novel hydrodynamically levitated centrifugal pump for long-term cardiopulmonary support : In vivo performance during percutaneous cardiopulmonary support.

Authors:  Tomonori Tsukiya; Toshihide Mizuno; Yoshiaki Takewa; Eisuke Tatsumi; Yoshiyuki Taenaka
Journal:  J Artif Organs       Date:  2015-05-15       Impact factor: 1.731

Review 3.  Journal of Artificial Organs 2012: the year in review.

Authors:  Y Sawa; E Tatsumi; T Tsukiya; K Matsuda; K Fukunaga; A Kishida; T Masuzawa; G Matsumiya; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2013-02-28       Impact factor: 1.731

4.  Single-center experience of the bridge-to-bridge strategy using the Nipro paracorporeal ventricular assist device.

Authors:  Shuichi Yoshitake; Osamu Kinoshita; Kan Nawata; Yasuhiro Hoshino; Yoshifumi Itoda; Mitsutoshi Kimura; Haruo Yamauchi; Minoru Ono
Journal:  J Artif Organs       Date:  2018-06-25       Impact factor: 1.731

5.  Efficacy of new pediatric extra-corporeal life support system (Endumo 2000) for postoperative management after Norwood operation.

Authors:  Takaya Hoashi; Koji Kagisaki; Takayuki Nishigaki; Kotaro Yoshida; Teruyuki Hayashi; Hajime Ichikawa
Journal:  J Artif Organs       Date:  2014-08-15       Impact factor: 1.731

6.  Outcome of Extracorporeal Ventricular Assist Device for Cardiogenic Shock as a Bridge to Transplantation.

Authors:  Hyo-Hyun Kim; Jung-Hoon Shin; Jung-Hwan Kim; Young-Nam Youn
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2020-12-05

7.  Novel temporary left ventricular assist system with hydrodynamically levitated bearing pump for bridge to decision: initial preclinical assessment in a goat model.

Authors:  Satoru Kishimoto; Yoshiaki Takewa; Tomonori Tsukiya; Toshihide Mizuno; Kazuma Date; Hirohito Sumikura; Yutaka Fujii; Kentaro Ohnuma; Konomi Togo; Nobumasa Katagiri; Noritsugu Naito; Yuichiro Kishimoto; Yoshinobu Nakamura; Motonobu Nishimura; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2017-09-12       Impact factor: 1.731

8.  Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.

Authors:  Norihide Fukushima; Eisuke Tatsumi; Osamu Seguchi; Yoshiaki Takewa; Toshimitsu Hamasaki; Kaori Onda; Haruko Yamamoto; Teruyuki Hayashi; Tomoyuki Fujita; Junjiro Kobayashi
Journal:  Cardiovasc Drugs Ther       Date:  2018-08       Impact factor: 3.727

9.  Palladium-Induced Temporal Internalization of MHC Class I Contributes to T Cell-Mediated Antigenicity.

Authors:  Koyu Ito; Takayuki Kanaseki; Serina Tokita; Toshihiko Torigoe; Noriyasu Hirasawa; Kouetsu Ogasawara
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.